Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03011372
Brief Title: A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement - (FIGHT-203)

First Submitted : January 4, 2017
First Submitted that Met QC Criteria : January 4, 2017
First Posted : January 5, 2017 (Estimate)

Last Update Submitted that Met QC Criteria : December 17, 2020
Last Update Posted : December 19, 2020